October 18, 2002 - Volume 16 - Issue 15
pp: F33-F47,1991-2104

The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis

Haubrich, Richard H; Kemper, Carol A; Hellmann, Nicholas S; More

AIDS . 16(15):F33-F40, October 18, 2002.

Lack of Epstein-Barr virus- and HIV-specific CD27− CD8+ T cells is associated with progression to viral disease in HIV-infection

van Baarle, Debbie; Kostense, Stefan; Hovenkamp, Egbert; More

AIDS . 16(15):2001-2011, October 18, 2002.

Concise Communication

Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluation

Stiegler, Gabriela; Armbruster, Christine; Vcelar, Brigitta; More

AIDS . 16(15):2019-2025, October 18, 2002.

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study – ANRS 082

Katlama, Christine; Carcelain, Guislaine; Duvivier, Claudine; More

AIDS . 16(15):2027-2034, October 18, 2002.

Prevalence and clinical correlates of HIV viremia (`blips') in patients with previous suppression below the limits of quantification

Sklar, Peter A; Ward, Douglas J; Baker, Rose K; More

AIDS . 16(15):2035-2041, October 18, 2002.

Concise Communications

Concise Communication

Pilot study of interferon alpha high-dose induction therapy in combination with ribavirin for chronic hepatitis C in HIV-co-infected patients

Rockstroh, Jürgen Kurt; Mudar, Mannah; Lichterfeld, Mathias; More

AIDS . 16(15):2083-2085, October 18, 2002.

1 2 3 4 5